$ATOS pardon the graphic image. Here are the results of nebulized heparin and N-acetylcysteine for smoke inhalational injury. Before (A-C) &amp; after (D-F). Why wouldn't $ATOS 's candidate work for COVID-19? Looking for $20 - $30 by September. #StockMarket #stocks #investing #invest https://t.co/VzsAw7Q7Nl